RELAPSED NON-HODGKIN LYMPHOMA

Clinical trials for RELAPSED NON-HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED NON-HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

New hope for Tough-to-Treat lymphoma: drug combo trial launches

Disease control Not yet recruiting

This study tests a new combination of drugs for adults with diffuse large B-cell lymphoma that has come back or not responded to standard treatments. The goal is to see if adding homoharringtonine and a BCL-2 inhibitor to rituximab and prednisone can safely shrink tumors. About 6…

Matched conditions: RELAPSED NON-HODGKIN LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated May 13, 2026 15:58 UTC

RELAPSED NON-HODGKIN LYMPHOMA

Get alerted when new RELAPSED NON-HODGKIN LYMPHOMA trials appear

New hope for Tough-to-Treat lymphoma: drug combo trial launches